7.780USD+7.780After-hours 08/03, 20:00 (ET)
1.26BMarket Cap
LossP/E TTM
Key Figures
7.800Open
8.145High
4.44MVolume
LossP/E TTM
18.69P/E Dynamic
--Dividend TTM
2.90%Turnover Ratio
7.780Prev. Close
7.700Low
21.67MTurnover
LossP/E Static
1.22P/B
0.00%Div Yield TTM
-0.99%ROA
13.88052wk High
0.96Volume Ratio
-12.05MNet Profit
153.33MShares
-0.0950EPS TTM
1.50Beta
-1.44%ROE
4.45052wk Low
5.72%Amplitude
47.43%Gross Margin
1.26BMarket Cap
2.60Reward/Risk
3.50%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Certara Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 104 out of 485 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 7.71.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Certara Inc Highlights
StrengthsRisks
Certara Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Palo Alto Networks Inc
PANW
57
CrowdStrike Holdings Inc
CRWD
55
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Certara Inc Info
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.
Ticker SymbolCERT
CompanyCertara Inc
CEOFeehery (William F)
Websitehttps://www.certara.com/
Shareholders
FAQs
What is the current price of Certara Inc (CERT)?
The current price of Certara Inc (CERT) is 8.10.
What is the symbol of Certara Inc?
The ticker symbol of Certara Inc is CERT.
What is the 52-week high of Certara Inc?
The 52-week high of Certara Inc is 13.88.
What is the 52-week low of Certara Inc?
The 52-week low of Certara Inc is 4.45.
What is the market capitalization of Certara Inc?
The market capitalization of Certara Inc is 1.26B.
Is Certara Inc (CERT) currently rated as Buy, Hold, or Sell?
According to analysts, Certara Inc (CERT) has an overall rating of signal_hold, with a price target of 7.71.
What is the Earnings Per Share (EPS TTM) of Certara Inc (CERT)?
The Earnings Per Share (EPS TTM) of Certara Inc (CERT) is -0.01.
